A pilot study of urinary peptides as biomarkers for intelligence in old age

Intelligence

Volumn 39, Issue 1, 2011, Pages 46-53

  Lopez, Lorna M ^a   Mullen, William ^b   Zürbig, Petra ^c   Harris, Sarah E ^a   Gow, Alan J ^a   Starr, John M ^a   Porteous, David J ^a   Mischak, Harald ^b,c   Deary, Ian J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c Mosaiques Diagnostics GmbH   (Germany)

Author keywords

Ageing; Intelligence; Peptide; Protein; Proteomics

Indexed keywords

EID: 78651317583     PISSN: 01602896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intell.2010.11.001     Document Type: Article

References (53)

1. Adachi J., Kumar C., Zhang Y., Olsen J.V., Mann M. The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biology 2006, 7:R80.
2. Airoldi L., Magagnotti C., Iannuzzi A.R., Marelli C., Bagnati R., Pastorelli R., et al. Effects of cigarette smoking on the human urinary proteome. Biochemical and Biophysical Research Communications 2009, 381:397-402.
3. Batty G.D., Deary I.J., Gottfredson L.S. Premorbid (early life) IQ and later mortality risk: systematic review. Annals of Epidemiology 2007, 17:278-288.
4. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society: Series B: Methodological 1995, 57.
5. Chalmers M.J., Mackay C.L., Hendrickson C.L., Wittke S., Walden M., Mischak H., et al. Combined top-down and bottom-up mass spectrometric approach to characterization of biomarkers for renal disease. Analytical Chemistry 2005, 77:7163-7171.
6. Coon J.J., Zürbig P., Dakna M., Dominiczak A.F., Decramer S., Fliser D., et al. CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics. Proteomics: Clinical Applications 2008, 2:964.
7. Deary I.J., Gow A.J., Taylor M.D., Corley J., Brett C., Wilson V., et al. The Lothian Birth Cohort 1936: a study to examine influences on cognitive ageing from age 11 to age 70 and beyond. BMC Geriatrics 2007, 7:28.
8. Deary I.J., Johnson W., Houlihan L.M. Genetic foundations of human intelligence. Human Genetics 2009, 126:215-232.
9. Deary I.J., Penke L., Johnson W. The neuroscience of human intelligence differences. Nature Review Neuroscience 2010, 11:201-211.
10. Deary I.J., Strand S., Smith P., Fernandes C. Intelligence and educational achievement. Intelligence 2007, 35:13-21.
11. Deary I.J., Whalley L.J., Starr J.M. A lifetime of intelligence: follow-up studies of the Scottish Mental Surveys of 1932 and 1936 2009, American Psychological Association, Washington, DC.
12. Decramer S., Wittke S., Mischak H., Zürbig P., Walden M., Bouissou F., et al. Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis. Nature Medicine 2006, 12:398-400.
13. Fliser D., Novak J., Thongboonkerd V., Argiles A., Jankowski V., Girolami M.A., et al. Advances in urinary proteome analysis and biomarker discovery. Journal of the American Society of Nephrology 2007, 18:1057-1071.
14. Giedraitis V., Kilander L., Degerman-Gunnarsson M., Sundelof J., Axelsson T., Syvanen A.C., et al. Genetic analysis of Alzheimer's disease in the Uppsala Longitudinal Study of Adult Men. Dementia and Geriatric Cognitive Disorders 2009, 27:59-68.
15. Gonzales P.A., Pisitkun T., Hoffert J.D., Tchapyjnikov D., Star R.A., Kleta R., et al. Large-Scale Proteomics and Phosphoproteomics of Urinary Exosomes. Journal of the American Society of Nephrology 2009, 20:363-379.
16. Good D.M., Zürbig P., Argiles A., Bauer H.W., Behrens G., Coon J.J., et al. Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Molecular & Cellular Proteomics 2010, 9:2424-2437.
17. Gottfredson L.S. Why g matters: The complexity of everyday life. Intelligence 1997, 24:79-132.
18. Harris S.E., Deary I.J., Maclntyre A., Lamb K.J., Radhakrishnan K., Starr J.M., et al. The association between telomere length, physical health, cognitive ageing, and mortality in non-demented older people. Neuroscience Letters 2006, 406:260-264.
19. Harris S.E., Fox H., Wright A.F., Hayward C., Starr J.M., Whalley L.J., et al. A genetic association analysis of cognitive ability and cognitive ageing using 325 markers for 109 genes associated with oxidative stress or cognition. BMC Genetics 2007, 8.
20. Houlihan L.M., Wyatt N.D., Harris S.E., Hayward C., Gow A.J., Marioni R.E., et al. Variation in the uric acid transporter gene (SLC2A9) and memory performance. Human Molecular Genetics 2010, 19:2321-2330.
21. Jantos-Siwy J., Schiffer E., Brand K., Schumann G., Rossing K., Delles C., et al. Quantitative Urinary Proteome Analysis for Biomarker Evaluation in Chronic Kidney Disease. Journal of Proteome Research 2009, 8:268-281.
22. Kolch W., Neususs C., Peizing M., Mischak H. Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery. Mass Spectrometry Reviews 2005, 24:959-977.
23. Luciano M., Marioni R.E., Gow A.J., Starr J.M., Deary I.J. Reverse causation in the association between c-reactive protein and fibrinogen levels and cognitive abilities in an aging sample. Psychosomatic Medicine 2009, 71:404-409.
24. Luckhaus C., Mahabadi B., Grass-Kapanke B., Janner M., Willenberg H., Jager M., et al. Blood biomarkers of osteoporosis in mild cognitive impairment and Alzheimer's disease. Journal of Neural Transmission 2009, 116:905-911.
25. MacLullich A.M.J., Deary I.J., Starr J.M., Ferguson K.J., Wardlaw J.M., Seckl J.R. Plasma cortisol levels, brain volumes and cognition in healthy elderly men. Psychoneuroendocrinology 2005, 30:505-515.
26. Meier M., Kaiser T., Herrmann A., Knueppel S., Hillmann M., Koester P., et al. Identification of urinary protein pattern in Type 1 diabetic adolescents with early diabetic nephropathy by a novel combined proteome analysis. Journal of Diabetes and its Complications 2005, 19:223-232.
27. Mischak H., Apweiler R., Banks R.E., Conaway M., Coon J., Dominiczak A., et al. Clinical proteomics: a need to define the field and to begin to set adequate standards. Proteomics: Clinical Applications 2007, 1:148-156.
28. Mischak H., Coon J.J., Novak J., Weissinger E.M., Schanstra J.P., Dominiczak A.F. Capillary electrophoresis-mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: an update of recent developments. Mass Spectrometry Reviews 2009, 28:703-724.
29. Mischak H., Julian B.A., Novak J. High-resolution proteome/peptidome analysis of peptides and low-molecular-weight proteins in urine. Proteomics: Clinical Applications 2007, 1:792-804.
30. Mischak H., Kaiser T., Walden M., Hillmann M., Wittke S., Herrmann A., et al. Proteomic analysis for the assessment of diabetic renal damage in humans. Clinical Science 2004, 107:485-495.
31. Mischak H., Kolch W., Aivaliotis M., Bouyssie D., Court M., Dihazi H., et al. Comprehensive human urine standards for comparability and standardization in clinical proteome analysis. Proteomics: Clinical Applications 2010, 4:464-478.
32. Plomin R., Kennedy J.K.J., Craig I.W. The quest for quantitative trait loci associated with intelligence. Intelligence 2006, 34:513-526.
33. Roesch-Ely M., Leipold A., Nees M., Holzinger D., Dietz A., Flechtenmacher C., et al. Proteomic analysis of field cancerization in pharynx and oesophagus: a prospective pilot study. The Journal of Pathology 2010, 221:462-470.
34. Rossing K., Mischak H., Dakna M., Zürbig P., Novak J., Julian B.A., et al. Urinary proteomics in diabetes and CKD. Journal of the American Society of Nephrology 2008, 19:1283-1290.
35. Rossing K., Mischak H., Rossing P., Schanstra J.P., Wiseman A., Maahs D.M. The urinary proteome in diabetes and diabetes-associated complications: new ways to assess disease progression and evaluate therapy. Proteomics: Clinical Applications 2008, 2:997-1007.
36. Schiffer E., Mischak H., Zimmerli L.U. Proteomics in gerontology: current applications and future aspects-a mini-review. Gerontology 2009, 55:123-137.
37. Shoichet S.A., Hoffmann K., Menzel C., Trautmann U., Moser B., Hoeltzenbein M., et al. Mutations in the ZNF41 gene are associated with cognitive deficits: identification of a new candidate for X-linked mental retardation. American Journal of Human Genetics 2003, 73:1341-1354.
38. Snell-Bergeon J.K., Maahs D.M., Ogden L.G., Kinney G.L., Hokanson J.E., Schiffer E., et al. Evaluation of urinary biomarkers for coronary artery disease, diabetes, and diabetic kidney disease. Diabetes Technology & Therapeutics 2009, 11:1-9.
39. Song F., Poljak A., Smythe G.A., Sachdev P. Plasma biomarkers for mild cognitive impairment and Alzheimer's disease. Brain Research Reviews 2009, 61:69-80.
40. Taylor C.F., Paton N.W., Lilley K.S., Binz P.A., Julian R.K., Jones A.R., et al. The minimum information about a proteomics experiment (MIAPE). Nature Biotechnology 2007, 25:887-893.
41. Theodorescu D., Fliser D., Wittke S., Mischak H., Krebs R., Walden M., et al. Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urine. Electrophoresis 2005, 26:2797-2808.
42. Theodorescu D., Wittke S., Ross M.M., Walden M., Conaway M., Just I., et al. Discovery and validation of new protein biomarkers for 4 urothelial cancer: a prospective analysis. The Lancet Oncology 2006, 7:230-240.
43. Thongboonkerd V. Practical points in urinary proteomics. Journal of Proteome Research 2007, 6:3881-3890.
44. Tong Y., Xu Y., Scearce-Levie K., Ptacek L.J., Fu Y.H. COL25A1 triggers and promotes Alzheimer's disease-like pathology in vivo. Neurogenetics 2010, 11:41-52.
45. von zur Muhlen C., Schiffer E., Zuerbig P., Kellmann M., Brasse M., Meert N., et al. Evaluation of urine proteome pattern analysis for its potential to reflect coronary artery atherosclerosis in symptomatic patients. Journal of Proteome Research 2009, 8:335-345.
46. Walters J.T.R., Corvin A., Owen M.J., Williams H., Dragovic M., Quinn E.M., et al. Psychosis susceptibility gene ZNF804A and cognitive performance in schizophrenia. Archives of General Psychiatry 2010, 67:692-700.
47. Wechsler D. WMS-III: Wechsler memory scale administration and scoring manual 1998, Psychological Corp. 3rd. ed.
48. Weissinger E.M., Schiffer E., Hertenstein B., Ferrara J.L., Holler E., Stadler M., et al. Proteomic patterns predict acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Blood 2007, 109:5511-5519.
49. Willemsen M.H., Fernandez B.A., Bacino C.A., Gerkes E., de Brouwer A.P.M., Pfundt R., et al. Identification of ANKRD11 and ZNF778 as candidate genes for autism and variable cognitive impairment in the novel 16q24.3 microdeletion syndrome. European Journal of Human Genetics 2010, 18:429-435.
50. Wittke S., Fliser D., Haubitz M., Bartel S., Krebs R., Hausadel F., et al. Determination of peptides and proteins in human urine with capillary electrophoresis-mass spectrometry, a suitable tool for the establishment of new diagnostic markers. Journal of Chromatography A 2003, 1013:173-181.
51. Zimmerli L.U., Schiffer E., Zürbig P., Good D.M., Kellmann M., Mouls L., et al. Urinary proteomic biomarkers on coronary artery disease. Molecular & Cellular Proteomics 2008, 7:290-298.
52. Zürbig P., Decramer S., Dakna M., Jantos J., Good D.M., Coon J.J., et al. The human urinary proteome reveals high similarity between kidney aging and chronic kidney disease. Proteomics 2009, 9:2108-2117.
53. Zürbig P., Renfrow M.B., Schiffer E., Novak J., Walden M., Wittke S., et al. Biomarker discovery by CE-MS enables sequence analysis via MS/MS with platform-independent separation. Electrophoresis 2006, 27:2111-2125.